GTLB enters its August 31 earnings report in an awkward spot: the stock has rallied 27% over the past month, yet short sellers haven't flinched, and analysts are scrambling to catch up with targets that still sit below the current price.
The tension in positioning is real, but it's less about the lending market and more about conviction. Short interest remains elevated at nearly 13% of the free float — roughly 19.1 million shares — and has barely moved over the past week, edging up just 0.3%. Shorts have been grinding lower over the past month, down about 1.3%, but the pace of covering is glacial relative to the stock's move. Borrow conditions offer no particular pressure on either side: the cost to borrow has eased to around 0.42%, well within normal territory and down 15% on the week, while availability is exceptionally loose at over 2,200% — more than 22 shares available in the lending pool for every one currently borrowed. There is no squeeze dynamic here. The short community is paying almost nothing to maintain these positions, and the pool of stock available to lend remains vast. On the options side, the put/call ratio of 0.51 is almost exactly in line with its 20-day average, with a z-score near zero — options traders are neither hedging more aggressively nor leaning bullishly into the rally. The setup reads as one of patient short conviction sitting alongside an unusually calm options market ahead of a catalyst.
The Street's reaction to the rally is where things get interesting. Two major names moved targets this week — B of A Securities raised to $45 while keeping a Neutral rating, and Mizuho lifted to $34 also at Neutral. RBC Capital moved to $46 earlier in the month. Despite the upgrades, the Street's consensus price target averages $36, below the current price of $41.50. That inversion — analysts raising targets yet still sitting below where the stock trades — reflects a Street that is fundamentally cautious but unwilling to be caught flat-footed if momentum continues. The bull case centres on GitLab's unified DevSecOps platform, consistent free cash flow generation, and the structural tailwind of AI-assisted development. The bear case is pointed: GitHub's resources under Microsoft, cautious FY27 guidance, and recent layoffs all raise questions about whether the revenue growth trajectory can sustain a valuation now trading at roughly 45x earnings and 6.2x book. The ORTEX short score of 51, sitting near the middle of its range, signals neither acute squeeze risk nor crowded short pressure — consistent with a stock where the debate is genuinely balanced.
Institutional flows add a layer of nuance. PRIMECAP built a position of 7.3 million shares as of April, and Impactive Capital entered with a fresh 3.9 million share position last quarter. AQR added over 3.2 million shares. These are active managers making deliberate bets, not passive accumulation. Offsetting that, the founder and Executive Chairman Sytse Sijbrandij sold over 116,000 shares across two transactions in June, including a block worth nearly $2.9 million. CEO William Staples, notably, bought 4,188 shares at $29.36 on June 30 — a modest but directional signal from the top of the house — before also having sold in mid-June at similar levels. The net insider picture over 90 days is technically positive at roughly 294,000 shares, but that figure is dominated by the CEO's June buy against a backdrop of consistent executive selling elsewhere.
The earnings history deserves attention given what's coming. The most recent print on June 2 produced a day-one drop of 8.5% that extended to a five-day loss of 10.3%. The June 17 event — which appears to capture a separate disclosure — saw a smaller 4.5% decline with a partial recovery to a 1.7% gain by day five. In both cases, the initial market reaction was negative. The stock now arrives at the August 31 report trading 58% above where it printed that June selloff low near $26, with shorts still holding 13% of the float and analysts trailing the price. The question heading into month-end is whether the recent analyst target revisions and institutional accumulation reflect genuine belief in an earnings inflection — or whether the pattern of post-report disappointment reasserts itself against a far more demanding starting valuation.
See the live data behind this article on ORTEX.
Open GTLB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
